Accès ouvert

Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2

Article scientifique 2026 Anglais

Résumé

Abstract Although inflammation protects our bodies against harmful stimuli, uncontrolled inflammation drives serious chronic disorders. Malva parviflora L. (family Malvaceae) may represent a source for anti-inflammatory metabolites based on its potent anti-inflammatory activity. Its total ethanol extract demonstrated notable inhibition of cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX), with IC 50 values comparable to those of the reference drugs indomethacin and zileuton, respectively. The hexane fraction was the most active fraction (lowest IC₅₀) among the solvent partitions (dichloromethane, ethyl acetate, and butanol). Subsequent column chromatography of the hexane fraction produced two compounds: Cassipourol, isolated for the first time from the Malvaceae family, and β -sitosterol. Their structures were confirmed by matching their NMR and mass spectrometry data with literature. Both were validated in vitro as dual COX/LOX inhibitors, exhibiting IC₅₀ values comparable to those of the standards. To uncover additional mechanisms, a compound–target–inflammation network was constructed using network pharmacology approaches, revealing 178 shared targets. Among these, tumor necrosis factor (TNF- α ) and the antiapoptotic protein B-cell lymphoma 2 (BCL-2) emerged as central nodes linked to inflammatory pathways. Subsequent assays in human colon carcinoma (Caco-2) and lung adenocarcinoma (A549) cell lines showed that β -sitosterol suppressed TNF- α and BCL-2 by approximately 55%, whereas cassipourol displayed only modest inhibition (~20%). Molecular docking predicted moderate ( ca. –4.5) and strong (> –5) binding affinities of both compounds to key inflammatory targets. Collectively, these results suggest that β -sitosterol from M. parviflora is a promising multitarget lead for inflammatory disorders, including cancer, whereas cassipourol requires further structural optimization and mechanistic investigation to improve its unfavorable physicochemical properties.

Citer ce document

Anwar, M., Gedaily, R., Aboulthana, W., Elshewy, A., Kandil, Z., Abdel-dayem, S. (2026). Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2. https://doi.org/10.1038/s41598-026-56631-1

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Statistiques

Consultations : 1

Téléchargements : 0